288 related articles for article (PubMed ID: 36095842)
1. The end of the beginning: application of single-cell sequencing to chronic lymphocytic leukemia.
Nagler A; Wu CJ
Blood; 2023 Jan; 141(4):369-379. PubMed ID: 36095842
[TBL] [Abstract][Full Text] [Related]
2. Novel insights into the biology of CLL.
Lanasa MC
Hematology Am Soc Hematol Educ Program; 2010; 2010():70-6. PubMed ID: 21239773
[TBL] [Abstract][Full Text] [Related]
3. Nurture versus nature: the microenvironment in chronic lymphocytic leukemia.
Burger JA
Hematology Am Soc Hematol Educ Program; 2011; 2011():96-103. PubMed ID: 22160019
[TBL] [Abstract][Full Text] [Related]
4. The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies.
Burger JA; Gribben JG
Semin Cancer Biol; 2014 Feb; 24():71-81. PubMed ID: 24018164
[TBL] [Abstract][Full Text] [Related]
5. Beyond bystanders: Myeloid cells in chronic lymphocytic leukemia.
Hanna BS; Öztürk S; Seiffert M
Mol Immunol; 2019 Jun; 110():77-87. PubMed ID: 29173971
[TBL] [Abstract][Full Text] [Related]
6. Recent revelations and future directions using single-cell technologies in chronic lymphocytic leukemia.
Oder B; Chatzidimitriou A; Langerak AW; Rosenquist R; Österholm C
Front Oncol; 2023; 13():1143811. PubMed ID: 37091144
[TBL] [Abstract][Full Text] [Related]
7. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
8. The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling.
Lorenzo-Herrero S; Sordo-Bahamonde C; Bretones G; Payer ÁR; González-Rodríguez AP; González-García E; Pérez-Escuredo J; Villa-Álvarez M; Núñez LE; Morís F; Gonzalez S; López-Soto A
Front Immunol; 2019; 10():2455. PubMed ID: 31681329
[TBL] [Abstract][Full Text] [Related]
9. Molecular map of chronic lymphocytic leukemia and its impact on outcome.
Knisbacher BA; Lin Z; Hahn CK; Nadeu F; Duran-Ferrer M; Stevenson KE; Tausch E; Delgado J; Barbera-Mourelle A; Taylor-Weiner A; Bousquets-Muñoz P; Diaz-Navarro A; Dunford A; Anand S; Kretzmer H; Gutierrez-Abril J; López-Tamargo S; Fernandes SM; Sun C; Sivina M; Rassenti LZ; Schneider C; Li S; Parida L; Meissner A; Aguet F; Burger JA; Wiestner A; Kipps TJ; Brown JR; Hallek M; Stewart C; Neuberg DS; Martín-Subero JI; Puente XS; Stilgenbauer S; Wu CJ; Campo E; Getz G
Nat Genet; 2022 Nov; 54(11):1664-1674. PubMed ID: 35927489
[TBL] [Abstract][Full Text] [Related]
10. Dissecting CLL through high-dimensional single-cell technologies.
Gohil SH; Wu CJ
Blood; 2019 Mar; 133(13):1446-1456. PubMed ID: 30728142
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic evolution and lineage histories of chronic lymphocytic leukaemia.
Gaiti F; Chaligne R; Gu H; Brand RM; Kothen-Hill S; Schulman RC; Grigorev K; Risso D; Kim KT; Pastore A; Huang KY; Alonso A; Sheridan C; Omans ND; Biederstedt E; Clement K; Wang L; Felsenfeld JA; Bhavsar EB; Aryee MJ; Allan JN; Furman R; Gnirke A; Wu CJ; Meissner A; Landau DA
Nature; 2019 May; 569(7757):576-580. PubMed ID: 31092926
[TBL] [Abstract][Full Text] [Related]
12. BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia.
Perini GF; Feres CCP; Teixeira LLC; Hamerschlak N
Curr Treat Options Oncol; 2021 Jun; 22(8):66. PubMed ID: 34110507
[TBL] [Abstract][Full Text] [Related]
13. The chronic lymphocytic leukemia microenvironment: Beyond the B-cell receptor.
Choi MY; Kashyap MK; Kumar D
Best Pract Res Clin Haematol; 2016 Mar; 29(1):40-53. PubMed ID: 27742071
[TBL] [Abstract][Full Text] [Related]
14. Using the biology of chronic lymphocytic leukemia to choose treatment.
Hillmen P
Hematology Am Soc Hematol Educ Program; 2011; 2011():104-9. PubMed ID: 22160020
[TBL] [Abstract][Full Text] [Related]
15. Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.
Mittal AK; Chaturvedi NK; Rai KJ; Gilling-Cutucache CE; Nordgren TM; Moragues M; Lu R; Opavsky R; Bociek GR; Weisenburger DD; Iqbal J; Joshi SS
Mol Med; 2014 Jul; 20(1):290-301. PubMed ID: 24800836
[TBL] [Abstract][Full Text] [Related]
16. CD markers variations in chronic lymphocytic leukemia: New insights into prognosis.
Vosoughi T; Bagheri M; Hosseinzadeh M; Ehsanpour A; Davari N; Saki N
J Cell Physiol; 2019 Nov; 234(11):19420-19439. PubMed ID: 31049958
[TBL] [Abstract][Full Text] [Related]
17. [Pathogenesis of chronic lymphocytic leukemia].
Fukuda T
Rinsho Ketsueki; 2015 Mar; 56(3):261-8. PubMed ID: 25876778
[TBL] [Abstract][Full Text] [Related]
18. The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia.
Sun C; Chen YC; Martinez Zurita A; Baptista MJ; Pittaluga S; Liu D; Rosebrock D; Gohil SH; Saba NS; Davies-Hill T; Herman SEM; Getz G; Pirooznia M; Wu CJ; Wiestner A
Blood Adv; 2023 Jan; 7(1):145-158. PubMed ID: 35358998
[TBL] [Abstract][Full Text] [Related]
19. Uncovering the DNA methylome in chronic lymphocytic leukemia.
Cahill N; Rosenquist R
Epigenetics; 2013 Feb; 8(2):138-48. PubMed ID: 23321535
[TBL] [Abstract][Full Text] [Related]
20. T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword.
Vlachonikola E; Stamatopoulos K; Chatzidimitriou A
Front Immunol; 2020; 11():612244. PubMed ID: 33552073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
